6867 research outputs found
Sort by
Introduction: Pathways to Prosperity for Adolescent Girls in Africa
No full textAfrica stands at a crossroads, with its future prosperity hinging on the policy and investment decisions it makes today. The continent has an opportunity to shape the trajectories of generations to come by investing in the success of a pivotal population: its adolescent girls. With over 145 million adolescent girls calling Africa home, the potential for transformative change is immense. Yet challenges persist: from high rates of child marriage to limited educational opportunities. Over half of African girls ages 15 to 19 are out of school or married or have children. How can African countries overcome these challenges to ensure that adolescent girls enter adulthood empowered to thrive? Pathways to Prosperity for Adolescent Girls in Africa, published by the World Bank, offers a groundbreaking road map for change
Le Questionnaire pour etre Administre aux Filles et aux Garçons dans les Clubs
No full textCe questionnaire a été conçu par le FGM Data Hub pour être administré aux filles et aux garçons participant aux clubs mis en place dans le cadre du programme The Girl Generation - Support to the Africa-led Movement (TGG-ALM) pour mettre fin aux MGF, financé par le FCDO.L\u27objectif était de générer des données pour suivre les changements dans les connaissances, les attitudes, les croyances, les pratiques et l\u27action en relation avec les MGF et les normes de genre chez les filles et les garçons participant aux clubs, ainsi que le degré de leur implication dans le programme
Stories of Change Tool
Get PDFThe purpose of this tool and guidance is to support implementing partners to collect Stories of Change for the purposes of learning and capturing results of their interventions (e.g., to report against the Results Framework). The tool was developed by the FGM Data Hub, with input and feedback from The Girl Generation: Support to the Africa-Led Movement to End Female Genital Mutilation, for use by implementing partners to gather insights on the nature of changes occurring in the community as a result of their interventions. It can be used at community level, and also with other programme participants (e.g. students/ professionals, activists or grantee partners who have taken part in programme training or other events). Any text to be used with programme participants (consent section, questions used to gather information) should be translated into people’s mother tongue in advance
Outil de récits de changement
No full textLe but de cet outil et de ce guide est d\u27aider les partenaires de mise en oeuvre à recueillir des récits de changement dans le but d\u27apprendre et de capturer les résultats de leurs interventions (par exemple, pour rendre compte par rapport au cadre de résultats). L\u27outil a été développé par le FGM Data Hub, avec la contribution et les retours de The Girl Generation: Support to the Africa-Led Movement to End Female Genital Mutilation, à l’intention des partenaires de mise en oeuvre afin de recueillir des informations sur la nature des changements survenant dans la communauté à la suite de leurs interventions. Il peut être utilisé au niveau communautaire, mais aussi avec d\u27autres participants au programme (par exemple, des étudiants/professionnels, des militants ou des partenaires bénéficiaires qui ont participé à une formation au programme ou à d\u27autres événements). Tout texte à utiliser avec les participants au programme (section de consentement, questions utilisées pour recueillir des informations) doit être traduit au préalable dans la langue maternelle des personnes
Adolescent Girls Initiative–Kenya: Testing for Scale—Recommendations Report
Get PDFThe Adolescent Girls Initiative-Kenya, a randomized trial implemented between 2015 and 2021, was designed to test the short- and longer-term effects of two-year multisectoral and multilevel “cash plus” programs for adolescent girls aged 11–14 years. It was implemented in two marginalized areas of Kenya: Kibera, an urban informal settlement in Nairobi, and Wajir, a pastoralist rural county. Results showed that a multisectoral approach was an effective way to create positive change across a range of well-being factors for young adolescent girls, including education, health, and economic outcomes. The program had long-term sustainable effects. Throughout the testing for scale phase, PC-Kenya demonstrated a commitment to assessing which program components had greatest impact, limits of feasibility, and cost calculations relative to country budgets. This report includes a high-level summary of the impact evaluation results on key indicators on education and gender norms, including both quantitative and qualitative data, as well as recommendations for scale up of the program jointly developed by PC-Kenya, Save the Children, and the Wajir County Government
Vaginal progesterone to prevent spontaneous preterm birth in women with a sonographic short cervix: The story of the PREGNANT trial
No full textThe PREGNANT trial was a randomized, placebo-controlled, multicenter trial designed to determine the efficacy and safety of vaginal progesterone (VP) to reduce the risk of birth \u3c 33 weeks and of neonatal complications in women with a sonographic short cervix (10 to 20 mm) in the mid-trimester (19 to 23 6/7 wk). Patients allocated to receive VP had a 45% lower rate of preterm birth (8.9% vs 16.1%; relative risk = 0.55; 95% CI: 0.33-0.92). Neonates born to mothers allocated to VP had a 60% reduction in the rate of respiratory distress syndrome. This article reviews the background, design, execution, interpretation, and impact of the PREGNANT Trial
Making a Smart Investment: Evidence that Worker Health Programs Benefit Everyone—Slide deck
Get PDFSlide deck for event held on 17 July 2024
Expert opinion on the use of contraception in people with multiple sclerosis
No full textBackground: Current guidance on the selection of appropriate contraception for people with multiple sclerosis (PwMS) is lacking. Objective: To address this gap, an expert-led consensus program developed recommendations to support clinicians in discussing family planning and contraception with women and men with multiple sclerosis (MS). Methods: A multidisciplinary steering committee (SC) of 13 international clinical experts led the program, supported by an extended faculty of 32 experts representing 18 countries. A modified Delphi methodology was used for decision-making and consensus-building. The SC drafted 15 clinical questions focused on patient-centered care, selection of contraception, and timing of stopping/starting contraception and disease-modifying therapies (DMTs). Statements addressing each question were drafted based on evaluation of published evidence and the experts’ clinical experience. Consensus was reached if ⩾75% of respondents agreed (scoring 7–9 on a 9-point scale) with each recommendation. Results: Consensus was reached on 24 of 25 proposed recommendations, including how and when to discuss contraception, types and safety of contraceptives, and how to evaluate the most appropriate contraceptive options for specific patient groups, including those with significant disability or being treated with DMTs. Conclusion: These expert recommendations provide the first practical, relevant, and comprehensive guidance for clinicians on the selection of contraception in PwMS
The role of advocacy in sustaining male contraceptive research and development
No full textNovel male contraceptives have been in development for well over half a century, and despite a robust predicted global market for new methods, funding for research and development has been extremely limited. While the pharmaceutical industry previously supported male contraceptive research and development, industry partners are only spectators in the current space, awaiting a product that has been de-risked by the public sector before re-entering the field. Current male contraceptive development efforts are thus primarily funded by nonprofit, non-governmental, and government agencies who also act as the primary advocates for the field. Specific organizations include the International Consortium on Male Contraception, the Population Council, the Male Contraceptive Initiative, the World Health Organization, and the US National Institutes of Health. The funding provided by these public agencies, alongside their social and policy-based advocacy efforts such as market research, public education, and calls to action have kept the male contraceptive product development space afloat, resulting in a pipeline of potential products advancing towards market approval. However, as these products mature into more expensive clinical stages of development, they continue to face significant funding challenges, which many programs may not overcome. To fully realize the benefits of novel male contraceptive options, it is incumbent on philanthropic entities, impact investors, venture capital, and/or the pharmaceutical sector to provide significant and timely support for male contraceptive research and development